Yuchun Lee, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,353 shares at $266.18 ($1.7M) on 2020-04-22, disclosed to the SEC on 2020-04-24.
Open-market sale of $1.7M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $265.16 | 300 | $80K | 4.6% |
| 2 | $265.16 | 300 | $80K | 4.6% |
| 3 | $266.18 | 300 | $80K | 4.7% |
| 4 | $267.34 | 507 | $136K | 7.9% |
| 5 | $267.34 | 507 | $136K | 7.9% |
| 6 | $268.48 | 224 |
| $60K |
| 3.5% |
| 7 | $268.48 | 224 | $60K | 3.5% |
| 8 | $269.47 | 300 | $81K | 4.7% |
| 9 | $269.47 | 300 | $81K | 4.7% |
| 10 | $270.54 | 369 | $100K | 5.8% |
| 11 | $270.54 | 369 | $100K | 5.8% |
| 12 | $267.47 | 353 | $94K | 5.5% |
| 13 | $267.47 | 353 | $94K | 5.5% |
| 14 | $269.23 | 200 | $54K | 3.1% |
| 15 | $271.03 | 300 | $81K | 4.7% |
| 16 | $271.03 | 300 | $81K | 4.7% |
| 17 | $272.55 | 100 | $27K | 1.6% |
| 18 | $274.23 | 400 | $110K | 6.4% |
| 19 | $275.90 | 600 | $166K | 9.7% |
| 20 | $276.45 | 47 | $13K | 0.8% |
| Total | $269.55 avg | 6,353 | $1.7M | 100% |
| Filing → |
| VRTX | SELL | 2023-01-25 | $3.8M | — | Filing → |
| VRTX | SELL | 2023-01-19 | $1.5M | — | Filing → |
| VRTX | SELL | 2022-04-20 | $1.1M | — | Filing → |